Enbiosis Biotechnology - Bio Diagnostic Franchise Opportunity
9.9 / 10 · Established in 2021, 13 Franchisees currently, Headquartered in London
All Formats
Format | Investment including Brand Fee | Brand Fee | Space | Staff | Exp. Monthly Sales | Profit Margin | Royalty |
---|---|---|---|---|---|---|---|
Pharmacies or Online Pharmacies | USD 60 thousand | USD 0 | 40 - 80 Sq Ft | 2 | USD 190 thousand | 20% | The total cost of the product to the Partner is approximately £125, which includes the Enbiosis software click fee of £25 per analysis. The Partner distributes the products to patients through pharmacies. Pharmacies purchase the product from the Partner for £160 and then sell it to patients for £240. |
Telehealth | USD 60 thousand | USD 0 | Not Required | 6 | USD 190 thousand | 40% | The Partner offers its customers comprehensive end-to-end gut health service. The total cost of the product to the Partner is approximately £125, which includes the Enbiosis software click fee of £25 per analysis. The Partner then sells this service to its clients for £250. |
Practitioner | USD 60 thousand | USD 0 | 40 - 50 Sq Ft | 5 | USD 190 thousand | 20% | The total cost of the product for the Partner is approximately £125, including the Enbiosis software click fee of £25 per analysis. Practitioners prescribe the product to patients, who then purchase it from the Partner for £240. Subsequently, the Partner pays an £80 commission to the practitioner. |
Format Name | Pharmacies or Online Pharmacies | Telehealth | Practitioner |
---|---|---|---|
Investment | USD 63 - 63 thousand | USD 63 - 63 thousand | USD 63 - 63 thousand |
Brand Fee | USD 0 | USD 0 | USD 0 |
Space | 40 - 80 Sq Ft | 0 - 0 Sq Ft | 40 - 50 Sq Ft |
Staff | 2 | 6 | 5 |
Expected Monthly Sales | USD 190 thousand | USD 190 thousand | USD 190 thousand |
Profit Margin | 20% | 40% | 20% |
Royalty / Commission | The total cost of the product to the Partner is approximately £125, which includes the Enbiosis software click fee of £25 per analysis. The Partner distributes the products to patients through pharmacies. Pharmacies purchase the product from the Partner for £160 and then sell it to patients for £240. | The Partner offers its customers comprehensive end-to-end gut health service. The total cost of the product to the Partner is approximately £125, which includes the Enbiosis software click fee of £25 per analysis. The Partner then sells this service to its clients for £250. | The total cost of the product for the Partner is approximately £125, including the Enbiosis software click fee of £25 per analysis. Practitioners prescribe the product to patients, who then purchase it from the Partner for £240. Subsequently, the Partner pays an £80 commission to the practitioner. |
Documents
About Enbiosis Biotechnology
- Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues.
- How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes.
- Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems.
- Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence.
- The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try.
- Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue.
- We have a trade registration certificate to operate.
Products and Services
1) AI-Powered Microbiome Analysis (Gut Health Report):
Potential disease risk analysis and general well-being indices.
2) Personalized nutrition guide:
Personalized food and meal recommendations. For practitioners, there is also an automatic diet planner.
3) Personalized Supplement (Prebiotic + Probiotic)
Preferred Locations
India, Japan, China, South Korea, Thailand, Canada, Australia, Vietnam, Germany, Spain, Italy, France, Romania, Hungary, Sweden, Czech Republic, Norway, Finland, Denmark.How to get Enbiosis Biotechnology Franchise?
Connect with us on SMERGERS and we will guide you through the process.
What are some of the things we look for in a Franchisee?
We will localize the AI, meaning we will integrate our technology into a local server so our partner can independently structure the business. Our responsibility is to provide the technology and its maintenance. Our partner should handle other aspects of the operation: marketing, sales, collecting stool samples from patients, and sending the samples to a local or any agreed-upon lab. We will either charge a fixed software click fee or request 15% of the revenue.
Support you can expect from the company
There will be a 3-month onboarding session. During the onboarding period, we will assist our partner in finding a lab, producing their own sample collection kit, and testing the first few samples. Parallelly, we will train their sales team and, if available, nutritionists or physicians. The partner can choose to use their own website and application to offer Enbiosis services. In that scenario, we will share our API with them for integration into their platform. If the partner prefers to use the Enbiosis website and application, we will customize these according to their needs, including local foods, meals, and supplements. In the case that they choose to use our local website and app, we will provide IT services.
-
Earlier than 15 daysDirector, Science-based Nutrition, Istanbul, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysPartner, Apparel & Accessories, Delhi, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Apparel Manufacturer, Surat, Individual Investor / Buyer connected with the Business
Profile Stats
- 10+ introductions
- 1000+ Page Views
- 400+ Investor Views
Bio Diagnostic franchise in Italy
·Bio Diagnostic franchise in Norway
·Bio Diagnostic franchise in Germany
·Bio Diagnostic franchise in China
·Bio Diagnostic franchise in Spain
·Bio Diagnostic franchise in Australia
·Bio Diagnostic franchise in Vietnam
·Bio Diagnostic franchise in Finland
·Bio Diagnostic franchise in Czech Republic
·Bio Diagnostic franchise in France
·Bio Diagnostic franchise in India
·Bio Diagnostic franchise in Romania
·Bio Diagnostic franchise in Canada
·Bio Diagnostic franchise in Japan
·Bio Diagnostic franchise in Hungary
·Bio Diagnostic franchise in Denmark
·Bio Diagnostic franchise in South Korea
·Bio Diagnostic franchise in Thailand
·Bio Diagnostic franchise in Sweden
Frequently
Asked
Questions
-
When was Enbiosis Biotechnology established?Enbiosis Biotechnology was established in 2021 in London and is reported to have 13 Franchisees currently
-
What is the investment required to take up Enbiosis Biotechnology Franchisee?Investment required is GBP 50 thousand.
-
What is the space requirement for taking up Enbiosis Biotechnology Franchisee?Space required ranges from 0 - 80 sq ft depending on the format.
-
What Franchisee formats does Enbiosis Biotechnology offer?Enbiosis Biotechnology offers 3 formats, i.e Pharmacies or Online Pharmacies,Telehealth,Practitioner.
-
How to get Enbiosis Biotechnology Franchisee?Connect with us on SMERGERS and we will guide you through the process.